nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2C9—brain cancer	0.574	1	CbGaD
Hydromorphone—CYP2D6—Lomustine—brain cancer	0.0679	0.253	CbGbCtD
Hydromorphone—CYP2D6—Hydroxyurea—brain cancer	0.0514	0.192	CbGbCtD
Hydromorphone—CYP3A4—Temozolomide—brain cancer	0.0508	0.189	CbGbCtD
Hydromorphone—PTGS1—Etoposide—brain cancer	0.0446	0.166	CbGbCtD
Hydromorphone—CYP3A4—Lomustine—brain cancer	0.0432	0.161	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—brain cancer	0.0104	0.0389	CbGbCtD
Hydromorphone—OPRM1—telencephalic ventricle—brain cancer	0.00314	0.123	CbGeAlD
Hydromorphone—OPRD1—ganglion—brain cancer	0.00286	0.112	CbGeAlD
Hydromorphone—OPRM1—ganglion—brain cancer	0.00195	0.0767	CbGeAlD
Hydromorphone—OPRD1—telencephalon—brain cancer	0.00111	0.0434	CbGeAlD
Hydromorphone—PTGS1—ganglion—brain cancer	0.000953	0.0374	CbGeAlD
Hydromorphone—UGT1A9—endocrine gland—brain cancer	0.000882	0.0346	CbGeAlD
Hydromorphone—OPRM1—brainstem—brain cancer	0.000849	0.0333	CbGeAlD
Hydromorphone—PTGS1—endothelium—brain cancer	0.000822	0.0323	CbGeAlD
Hydromorphone—PTGS1—blood vessel—brain cancer	0.000758	0.0297	CbGeAlD
Hydromorphone—OPRM1—telencephalon—brain cancer	0.000754	0.0296	CbGeAlD
Hydromorphone—OPRD1—head—brain cancer	0.000688	0.027	CbGeAlD
Hydromorphone—OPRK1—head—brain cancer	0.00066	0.0259	CbGeAlD
Hydromorphone—OPRD1—central nervous system—brain cancer	0.000628	0.0247	CbGeAlD
Hydromorphone—OPRK1—central nervous system—brain cancer	0.000602	0.0236	CbGeAlD
Hydromorphone—CYP2D6—hindbrain—brain cancer	0.000594	0.0233	CbGeAlD
Hydromorphone—OPRK1—cerebellum—brain cancer	0.000589	0.0231	CbGeAlD
Hydromorphone—OPRM1—midbrain—brain cancer	0.000541	0.0212	CbGeAlD
Hydromorphone—OPRM1—spinal cord—brain cancer	0.000528	0.0207	CbGeAlD
Hydromorphone—OPRD1—brain—brain cancer	0.000499	0.0196	CbGeAlD
Hydromorphone—OPRK1—brain—brain cancer	0.000478	0.0188	CbGeAlD
Hydromorphone—OPRM1—endocrine gland—brain cancer	0.000475	0.0187	CbGeAlD
Hydromorphone—OPRM1—head—brain cancer	0.000469	0.0184	CbGeAlD
Hydromorphone—OPRM1—central nervous system—brain cancer	0.000428	0.0168	CbGeAlD
Hydromorphone—PTGS1—telencephalon—brain cancer	0.000368	0.0144	CbGeAlD
Hydromorphone—CYP2D6—brainstem—brain cancer	0.000341	0.0134	CbGeAlD
Hydromorphone—OPRM1—brain—brain cancer	0.00034	0.0133	CbGeAlD
Hydromorphone—CYP2D6—telencephalon—brain cancer	0.000302	0.0119	CbGeAlD
Hydromorphone—PTGS1—pituitary gland—brain cancer	0.000299	0.0117	CbGeAlD
Hydromorphone—Depression—Carmustine—brain cancer	0.000298	0.00229	CcSEcCtD
Hydromorphone—Chills—Hydroxyurea—brain cancer	0.000298	0.00229	CcSEcCtD
Hydromorphone—Tachycardia—Procarbazine—brain cancer	0.000298	0.00228	CcSEcCtD
Hydromorphone—Hyperhidrosis—Procarbazine—brain cancer	0.000295	0.00226	CcSEcCtD
Hydromorphone—Weight decreased—Temozolomide—brain cancer	0.000293	0.00225	CcSEcCtD
Hydromorphone—Stomatitis—Carmustine—brain cancer	0.000291	0.00224	CcSEcCtD
Hydromorphone—Anorexia—Procarbazine—brain cancer	0.000291	0.00223	CcSEcCtD
Hydromorphone—Erythema—Hydroxyurea—brain cancer	0.000289	0.00222	CcSEcCtD
Hydromorphone—Infestation NOS—Temozolomide—brain cancer	0.000289	0.00222	CcSEcCtD
Hydromorphone—Infestation—Temozolomide—brain cancer	0.000289	0.00222	CcSEcCtD
Hydromorphone—Depression—Temozolomide—brain cancer	0.000288	0.00221	CcSEcCtD
Hydromorphone—Cardiac arrest—Etoposide—brain cancer	0.000285	0.00219	CcSEcCtD
Hydromorphone—Nausea—Lomustine—brain cancer	0.000285	0.00219	CcSEcCtD
Hydromorphone—Hypotension—Procarbazine—brain cancer	0.000285	0.00219	CcSEcCtD
Hydromorphone—Stomatitis—Temozolomide—brain cancer	0.000282	0.00216	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000278	0.00213	CcSEcCtD
Hydromorphone—Insomnia—Procarbazine—brain cancer	0.000276	0.00212	CcSEcCtD
Hydromorphone—Paraesthesia—Procarbazine—brain cancer	0.000274	0.0021	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Temozolomide—brain cancer	0.000273	0.0021	CcSEcCtD
Hydromorphone—Somnolence—Procarbazine—brain cancer	0.000271	0.00208	CcSEcCtD
Hydromorphone—Cramp muscle—Etoposide—brain cancer	0.00027	0.00207	CcSEcCtD
Hydromorphone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000268	0.00206	CcSEcCtD
Hydromorphone—Hallucination—Carmustine—brain cancer	0.000267	0.00205	CcSEcCtD
Hydromorphone—Hypoaesthesia—Carmustine—brain cancer	0.000267	0.00205	CcSEcCtD
Hydromorphone—Decreased appetite—Procarbazine—brain cancer	0.000265	0.00203	CcSEcCtD
Hydromorphone—Oedema peripheral—Carmustine—brain cancer	0.000264	0.00203	CcSEcCtD
Hydromorphone—Connective tissue disorder—Carmustine—brain cancer	0.000264	0.00202	CcSEcCtD
Hydromorphone—Fatigue—Procarbazine—brain cancer	0.000263	0.00202	CcSEcCtD
Hydromorphone—Malaise—Hydroxyurea—brain cancer	0.000261	0.002	CcSEcCtD
Hydromorphone—Pain—Procarbazine—brain cancer	0.000261	0.002	CcSEcCtD
Hydromorphone—Constipation—Procarbazine—brain cancer	0.000261	0.002	CcSEcCtD
Hydromorphone—Dysphagia—Etoposide—brain cancer	0.000259	0.00199	CcSEcCtD
Hydromorphone—Leukopenia—Hydroxyurea—brain cancer	0.000259	0.00199	CcSEcCtD
Hydromorphone—Visual impairment—Carmustine—brain cancer	0.000259	0.00198	CcSEcCtD
Hydromorphone—Hypoaesthesia—Temozolomide—brain cancer	0.000258	0.00198	CcSEcCtD
Hydromorphone—Hallucination—Temozolomide—brain cancer	0.000258	0.00198	CcSEcCtD
Hydromorphone—PTGS1—spinal cord—brain cancer	0.000258	0.0101	CbGeAlD
Hydromorphone—Urinary tract disorder—Temozolomide—brain cancer	0.000256	0.00197	CcSEcCtD
Hydromorphone—Oedema peripheral—Temozolomide—brain cancer	0.000256	0.00196	CcSEcCtD
Hydromorphone—Bronchospasm—Etoposide—brain cancer	0.000255	0.00196	CcSEcCtD
Hydromorphone—Connective tissue disorder—Temozolomide—brain cancer	0.000255	0.00196	CcSEcCtD
Hydromorphone—Urethral disorder—Temozolomide—brain cancer	0.000254	0.00195	CcSEcCtD
Hydromorphone—CYP2C9—endocrine gland—brain cancer	0.000254	0.00997	CbGeAlD
Hydromorphone—Sweating increased—Etoposide—brain cancer	0.000253	0.00194	CcSEcCtD
Hydromorphone—Feeling abnormal—Procarbazine—brain cancer	0.000251	0.00193	CcSEcCtD
Hydromorphone—Eye disorder—Carmustine—brain cancer	0.000251	0.00192	CcSEcCtD
Hydromorphone—Convulsion—Hydroxyurea—brain cancer	0.00025	0.00192	CcSEcCtD
Hydromorphone—Visual impairment—Temozolomide—brain cancer	0.00025	0.00192	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Procarbazine—brain cancer	0.000249	0.00191	CcSEcCtD
Hydromorphone—Flushing—Carmustine—brain cancer	0.000249	0.00191	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000244	0.00188	CcSEcCtD
Hydromorphone—Discomfort—Hydroxyurea—brain cancer	0.000243	0.00187	CcSEcCtD
Hydromorphone—Eye disorder—Temozolomide—brain cancer	0.000242	0.00186	CcSEcCtD
Hydromorphone—Urticaria—Procarbazine—brain cancer	0.000242	0.00186	CcSEcCtD
Hydromorphone—Tinnitus—Temozolomide—brain cancer	0.000242	0.00186	CcSEcCtD
Hydromorphone—Abdominal pain—Procarbazine—brain cancer	0.000241	0.00185	CcSEcCtD
Hydromorphone—Body temperature increased—Procarbazine—brain cancer	0.000241	0.00185	CcSEcCtD
Hydromorphone—Flushing—Temozolomide—brain cancer	0.000241	0.00185	CcSEcCtD
Hydromorphone—Cardiac disorder—Temozolomide—brain cancer	0.000241	0.00185	CcSEcCtD
Hydromorphone—Arrhythmia—Carmustine—brain cancer	0.00024	0.00184	CcSEcCtD
Hydromorphone—Angiopathy—Temozolomide—brain cancer	0.000235	0.00181	CcSEcCtD
Hydromorphone—Mental disorder—Carmustine—brain cancer	0.000235	0.0018	CcSEcCtD
Hydromorphone—Infection—Hydroxyurea—brain cancer	0.000234	0.0018	CcSEcCtD
Hydromorphone—Immune system disorder—Temozolomide—brain cancer	0.000234	0.0018	CcSEcCtD
Hydromorphone—Mediastinal disorder—Temozolomide—brain cancer	0.000234	0.00179	CcSEcCtD
Hydromorphone—Erythema—Carmustine—brain cancer	0.000234	0.00179	CcSEcCtD
Hydromorphone—Malnutrition—Carmustine—brain cancer	0.000234	0.00179	CcSEcCtD
Hydromorphone—Chills—Temozolomide—brain cancer	0.000233	0.00179	CcSEcCtD
Hydromorphone—PTGS1—endocrine gland—brain cancer	0.000232	0.0091	CbGeAlD
Hydromorphone—Nervous system disorder—Hydroxyurea—brain cancer	0.000231	0.00178	CcSEcCtD
Hydromorphone—Infestation—Etoposide—brain cancer	0.000231	0.00177	CcSEcCtD
Hydromorphone—Infestation NOS—Etoposide—brain cancer	0.000231	0.00177	CcSEcCtD
Hydromorphone—Skin disorder—Hydroxyurea—brain cancer	0.000229	0.00176	CcSEcCtD
Hydromorphone—PTGS1—head—brain cancer	0.000229	0.00898	CbGeAlD
Hydromorphone—Mental disorder—Temozolomide—brain cancer	0.000227	0.00174	CcSEcCtD
Hydromorphone—Back pain—Carmustine—brain cancer	0.000226	0.00173	CcSEcCtD
Hydromorphone—Malnutrition—Temozolomide—brain cancer	0.000226	0.00173	CcSEcCtD
Hydromorphone—Erythema—Temozolomide—brain cancer	0.000226	0.00173	CcSEcCtD
Hydromorphone—Stomatitis—Etoposide—brain cancer	0.000225	0.00173	CcSEcCtD
Hydromorphone—Anorexia—Hydroxyurea—brain cancer	0.000225	0.00173	CcSEcCtD
Hydromorphone—Hypersensitivity—Procarbazine—brain cancer	0.000225	0.00172	CcSEcCtD
Hydromorphone—Dysgeusia—Temozolomide—brain cancer	0.000221	0.0017	CcSEcCtD
Hydromorphone—Vision blurred—Carmustine—brain cancer	0.00022	0.00169	CcSEcCtD
Hydromorphone—Tremor—Carmustine—brain cancer	0.000219	0.00168	CcSEcCtD
Hydromorphone—Asthenia—Procarbazine—brain cancer	0.000219	0.00168	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Etoposide—brain cancer	0.000219	0.00168	CcSEcCtD
Hydromorphone—Back pain—Temozolomide—brain cancer	0.000218	0.00168	CcSEcCtD
Hydromorphone—Pruritus—Procarbazine—brain cancer	0.000216	0.00165	CcSEcCtD
Hydromorphone—Agitation—Carmustine—brain cancer	0.000215	0.00165	CcSEcCtD
Hydromorphone—Vision blurred—Temozolomide—brain cancer	0.000213	0.00163	CcSEcCtD
Hydromorphone—Tremor—Temozolomide—brain cancer	0.000212	0.00162	CcSEcCtD
Hydromorphone—Dyspnoea—Hydroxyurea—brain cancer	0.00021	0.00161	CcSEcCtD
Hydromorphone—Somnolence—Hydroxyurea—brain cancer	0.00021	0.00161	CcSEcCtD
Hydromorphone—Ill-defined disorder—Temozolomide—brain cancer	0.00021	0.00161	CcSEcCtD
Hydromorphone—Leukopenia—Carmustine—brain cancer	0.000209	0.0016	CcSEcCtD
Hydromorphone—PTGS1—central nervous system—brain cancer	0.000209	0.0082	CbGeAlD
Hydromorphone—Diarrhoea—Procarbazine—brain cancer	0.000209	0.0016	CcSEcCtD
Hydromorphone—Dyspepsia—Hydroxyurea—brain cancer	0.000208	0.00159	CcSEcCtD
Hydromorphone—Agitation—Temozolomide—brain cancer	0.000208	0.00159	CcSEcCtD
Hydromorphone—Hypoaesthesia—Etoposide—brain cancer	0.000207	0.00158	CcSEcCtD
Hydromorphone—Angioedema—Temozolomide—brain cancer	0.000206	0.00158	CcSEcCtD
Hydromorphone—Decreased appetite—Hydroxyurea—brain cancer	0.000205	0.00157	CcSEcCtD
Hydromorphone—Urinary tract disorder—Etoposide—brain cancer	0.000205	0.00157	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000204	0.00156	CcSEcCtD
Hydromorphone—Malaise—Temozolomide—brain cancer	0.000204	0.00156	CcSEcCtD
Hydromorphone—Urethral disorder—Etoposide—brain cancer	0.000203	0.00156	CcSEcCtD
Hydromorphone—Fatigue—Hydroxyurea—brain cancer	0.000203	0.00156	CcSEcCtD
Hydromorphone—Vertigo—Temozolomide—brain cancer	0.000203	0.00156	CcSEcCtD
Hydromorphone—Convulsion—Carmustine—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Leukopenia—Temozolomide—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Hypertension—Carmustine—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Pain—Hydroxyurea—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Constipation—Hydroxyurea—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Dizziness—Procarbazine—brain cancer	0.000202	0.00155	CcSEcCtD
Hydromorphone—Palpitations—Temozolomide—brain cancer	0.0002	0.00153	CcSEcCtD
Hydromorphone—Chest pain—Carmustine—brain cancer	0.000199	0.00153	CcSEcCtD
Hydromorphone—Myalgia—Carmustine—brain cancer	0.000199	0.00153	CcSEcCtD
Hydromorphone—Anxiety—Carmustine—brain cancer	0.000198	0.00152	CcSEcCtD
Hydromorphone—Cough—Temozolomide—brain cancer	0.000197	0.00151	CcSEcCtD
Hydromorphone—Convulsion—Temozolomide—brain cancer	0.000196	0.0015	CcSEcCtD
Hydromorphone—Hypertension—Temozolomide—brain cancer	0.000195	0.0015	CcSEcCtD
Hydromorphone—Feeling abnormal—Hydroxyurea—brain cancer	0.000194	0.00149	CcSEcCtD
Hydromorphone—Eye disorder—Etoposide—brain cancer	0.000194	0.00149	CcSEcCtD
Hydromorphone—Vomiting—Procarbazine—brain cancer	0.000194	0.00149	CcSEcCtD
Hydromorphone—CYP3A4—endocrine gland—brain cancer	0.000194	0.0076	CbGeAlD
Hydromorphone—Flushing—Etoposide—brain cancer	0.000193	0.00148	CcSEcCtD
Hydromorphone—Cardiac disorder—Etoposide—brain cancer	0.000193	0.00148	CcSEcCtD
Hydromorphone—Confusional state—Carmustine—brain cancer	0.000192	0.00148	CcSEcCtD
Hydromorphone—Arthralgia—Temozolomide—brain cancer	0.000192	0.00148	CcSEcCtD
Hydromorphone—Myalgia—Temozolomide—brain cancer	0.000192	0.00148	CcSEcCtD
Hydromorphone—Rash—Procarbazine—brain cancer	0.000192	0.00147	CcSEcCtD
Hydromorphone—Dermatitis—Procarbazine—brain cancer	0.000192	0.00147	CcSEcCtD
Hydromorphone—Anxiety—Temozolomide—brain cancer	0.000192	0.00147	CcSEcCtD
Hydromorphone—Headache—Procarbazine—brain cancer	0.000191	0.00147	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000191	0.00146	CcSEcCtD
Hydromorphone—CYP2D6—endocrine gland—brain cancer	0.000191	0.00748	CbGeAlD
Hydromorphone—Discomfort—Temozolomide—brain cancer	0.00019	0.00146	CcSEcCtD
Hydromorphone—Infection—Carmustine—brain cancer	0.000189	0.00145	CcSEcCtD
Hydromorphone—Angiopathy—Etoposide—brain cancer	0.000188	0.00145	CcSEcCtD
Hydromorphone—CYP2D6—head—brain cancer	0.000188	0.00738	CbGeAlD
Hydromorphone—Dry mouth—Temozolomide—brain cancer	0.000188	0.00144	CcSEcCtD
Hydromorphone—Immune system disorder—Etoposide—brain cancer	0.000187	0.00144	CcSEcCtD
Hydromorphone—Mediastinal disorder—Etoposide—brain cancer	0.000187	0.00144	CcSEcCtD
Hydromorphone—Body temperature increased—Hydroxyurea—brain cancer	0.000186	0.00143	CcSEcCtD
Hydromorphone—Chills—Etoposide—brain cancer	0.000186	0.00143	CcSEcCtD
Hydromorphone—Tachycardia—Carmustine—brain cancer	0.000186	0.00143	CcSEcCtD
Hydromorphone—Confusional state—Temozolomide—brain cancer	0.000186	0.00143	CcSEcCtD
Hydromorphone—Anaphylactic shock—Temozolomide—brain cancer	0.000184	0.00141	CcSEcCtD
Hydromorphone—Infection—Temozolomide—brain cancer	0.000183	0.0014	CcSEcCtD
Hydromorphone—Anorexia—Carmustine—brain cancer	0.000182	0.00139	CcSEcCtD
Hydromorphone—Nausea—Procarbazine—brain cancer	0.000181	0.00139	CcSEcCtD
Hydromorphone—Nervous system disorder—Temozolomide—brain cancer	0.000181	0.00139	CcSEcCtD
Hydromorphone—Skin disorder—Temozolomide—brain cancer	0.000179	0.00137	CcSEcCtD
Hydromorphone—Hypotension—Carmustine—brain cancer	0.000178	0.00137	CcSEcCtD
Hydromorphone—Hyperhidrosis—Temozolomide—brain cancer	0.000178	0.00137	CcSEcCtD
Hydromorphone—Dysgeusia—Etoposide—brain cancer	0.000177	0.00136	CcSEcCtD
Hydromorphone—Anorexia—Temozolomide—brain cancer	0.000176	0.00135	CcSEcCtD
Hydromorphone—Back pain—Etoposide—brain cancer	0.000175	0.00134	CcSEcCtD
Hydromorphone—CYP3A4—central nervous system—brain cancer	0.000175	0.00685	CbGeAlD
Hydromorphone—Hypersensitivity—Hydroxyurea—brain cancer	0.000174	0.00133	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000174	0.00133	CcSEcCtD
Hydromorphone—Muscle spasms—Etoposide—brain cancer	0.000174	0.00133	CcSEcCtD
Hydromorphone—Insomnia—Carmustine—brain cancer	0.000172	0.00132	CcSEcCtD
Hydromorphone—CYP2D6—central nervous system—brain cancer	0.000172	0.00674	CbGeAlD
Hydromorphone—Paraesthesia—Carmustine—brain cancer	0.000171	0.00131	CcSEcCtD
Hydromorphone—Dyspnoea—Carmustine—brain cancer	0.00017	0.0013	CcSEcCtD
Hydromorphone—Somnolence—Carmustine—brain cancer	0.00017	0.0013	CcSEcCtD
Hydromorphone—Asthenia—Hydroxyurea—brain cancer	0.000169	0.0013	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000168	0.00129	CcSEcCtD
Hydromorphone—CYP2D6—cerebellum—brain cancer	0.000168	0.00659	CbGeAlD
Hydromorphone—Ill-defined disorder—Etoposide—brain cancer	0.000168	0.00129	CcSEcCtD
Hydromorphone—Insomnia—Temozolomide—brain cancer	0.000167	0.00128	CcSEcCtD
Hydromorphone—PTGS1—brain—brain cancer	0.000166	0.00651	CbGeAlD
Hydromorphone—Decreased appetite—Carmustine—brain cancer	0.000166	0.00127	CcSEcCtD
Hydromorphone—Paraesthesia—Temozolomide—brain cancer	0.000165	0.00127	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Carmustine—brain cancer	0.000165	0.00126	CcSEcCtD
Hydromorphone—Dyspnoea—Temozolomide—brain cancer	0.000164	0.00126	CcSEcCtD
Hydromorphone—Somnolence—Temozolomide—brain cancer	0.000164	0.00126	CcSEcCtD
Hydromorphone—Constipation—Carmustine—brain cancer	0.000163	0.00125	CcSEcCtD
Hydromorphone—Pain—Carmustine—brain cancer	0.000163	0.00125	CcSEcCtD
Hydromorphone—Malaise—Etoposide—brain cancer	0.000163	0.00125	CcSEcCtD
Hydromorphone—Vertigo—Etoposide—brain cancer	0.000162	0.00125	CcSEcCtD
Hydromorphone—Dyspepsia—Temozolomide—brain cancer	0.000162	0.00124	CcSEcCtD
Hydromorphone—Leukopenia—Etoposide—brain cancer	0.000162	0.00124	CcSEcCtD
Hydromorphone—Diarrhoea—Hydroxyurea—brain cancer	0.000161	0.00124	CcSEcCtD
Hydromorphone—Decreased appetite—Temozolomide—brain cancer	0.00016	0.00123	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000159	0.00122	CcSEcCtD
Hydromorphone—Fatigue—Temozolomide—brain cancer	0.000159	0.00122	CcSEcCtD
Hydromorphone—Loss of consciousness—Etoposide—brain cancer	0.000159	0.00122	CcSEcCtD
Hydromorphone—Cough—Etoposide—brain cancer	0.000158	0.00121	CcSEcCtD
Hydromorphone—Pain—Temozolomide—brain cancer	0.000158	0.00121	CcSEcCtD
Hydromorphone—Constipation—Temozolomide—brain cancer	0.000158	0.00121	CcSEcCtD
Hydromorphone—Feeling abnormal—Carmustine—brain cancer	0.000157	0.00121	CcSEcCtD
Hydromorphone—Convulsion—Etoposide—brain cancer	0.000157	0.0012	CcSEcCtD
Hydromorphone—Hypertension—Etoposide—brain cancer	0.000156	0.0012	CcSEcCtD
Hydromorphone—Dizziness—Hydroxyurea—brain cancer	0.000156	0.0012	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Carmustine—brain cancer	0.000156	0.0012	CcSEcCtD
Hydromorphone—Chest pain—Etoposide—brain cancer	0.000154	0.00118	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000153	0.00117	CcSEcCtD
Hydromorphone—Discomfort—Etoposide—brain cancer	0.000152	0.00117	CcSEcCtD
Hydromorphone—Feeling abnormal—Temozolomide—brain cancer	0.000152	0.00117	CcSEcCtD
Hydromorphone—Abdominal pain—Carmustine—brain cancer	0.000151	0.00116	CcSEcCtD
Hydromorphone—Body temperature increased—Carmustine—brain cancer	0.000151	0.00116	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Temozolomide—brain cancer	0.000151	0.00116	CcSEcCtD
Hydromorphone—Vomiting—Hydroxyurea—brain cancer	0.00015	0.00115	CcSEcCtD
Hydromorphone—Rash—Hydroxyurea—brain cancer	0.000149	0.00114	CcSEcCtD
Hydromorphone—Confusional state—Etoposide—brain cancer	0.000149	0.00114	CcSEcCtD
Hydromorphone—Dermatitis—Hydroxyurea—brain cancer	0.000149	0.00114	CcSEcCtD
Hydromorphone—Headache—Hydroxyurea—brain cancer	0.000148	0.00113	CcSEcCtD
Hydromorphone—Anaphylactic shock—Etoposide—brain cancer	0.000147	0.00113	CcSEcCtD
Hydromorphone—Infection—Etoposide—brain cancer	0.000147	0.00112	CcSEcCtD
Hydromorphone—Urticaria—Temozolomide—brain cancer	0.000146	0.00112	CcSEcCtD
Hydromorphone—Body temperature increased—Temozolomide—brain cancer	0.000146	0.00112	CcSEcCtD
Hydromorphone—Abdominal pain—Temozolomide—brain cancer	0.000146	0.00112	CcSEcCtD
Hydromorphone—Tachycardia—Etoposide—brain cancer	0.000144	0.0011	CcSEcCtD
Hydromorphone—Skin disorder—Etoposide—brain cancer	0.000143	0.0011	CcSEcCtD
Hydromorphone—Hyperhidrosis—Etoposide—brain cancer	0.000143	0.00109	CcSEcCtD
Hydromorphone—Anorexia—Etoposide—brain cancer	0.000141	0.00108	CcSEcCtD
Hydromorphone—Hypersensitivity—Carmustine—brain cancer	0.000141	0.00108	CcSEcCtD
Hydromorphone—Nausea—Hydroxyurea—brain cancer	0.00014	0.00108	CcSEcCtD
Hydromorphone—Hypotension—Etoposide—brain cancer	0.000138	0.00106	CcSEcCtD
Hydromorphone—Asthenia—Carmustine—brain cancer	0.000137	0.00105	CcSEcCtD
Hydromorphone—CYP2D6—brain—brain cancer	0.000136	0.00535	CbGeAlD
Hydromorphone—Hypersensitivity—Temozolomide—brain cancer	0.000136	0.00104	CcSEcCtD
Hydromorphone—Paraesthesia—Etoposide—brain cancer	0.000132	0.00102	CcSEcCtD
Hydromorphone—Asthenia—Temozolomide—brain cancer	0.000132	0.00101	CcSEcCtD
Hydromorphone—Dyspnoea—Etoposide—brain cancer	0.000131	0.00101	CcSEcCtD
Hydromorphone—Somnolence—Etoposide—brain cancer	0.000131	0.00101	CcSEcCtD
Hydromorphone—Diarrhoea—Carmustine—brain cancer	0.00013	0.001	CcSEcCtD
Hydromorphone—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00013	0.0712	CbGpPWpGaD
Hydromorphone—Pruritus—Temozolomide—brain cancer	0.00013	0.001	CcSEcCtD
Hydromorphone—Decreased appetite—Etoposide—brain cancer	0.000128	0.000984	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Etoposide—brain cancer	0.000127	0.000977	CcSEcCtD
Hydromorphone—Fatigue—Etoposide—brain cancer	0.000127	0.000976	CcSEcCtD
Hydromorphone—Dizziness—Carmustine—brain cancer	0.000126	0.000968	CcSEcCtD
Hydromorphone—Pain—Etoposide—brain cancer	0.000126	0.000968	CcSEcCtD
Hydromorphone—Constipation—Etoposide—brain cancer	0.000126	0.000968	CcSEcCtD
Hydromorphone—Diarrhoea—Temozolomide—brain cancer	0.000126	0.000968	CcSEcCtD
Hydromorphone—Dizziness—Temozolomide—brain cancer	0.000122	0.000935	CcSEcCtD
Hydromorphone—Feeling abnormal—Etoposide—brain cancer	0.000122	0.000932	CcSEcCtD
Hydromorphone—Vomiting—Carmustine—brain cancer	0.000121	0.00093	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Etoposide—brain cancer	0.000121	0.000925	CcSEcCtD
Hydromorphone—Rash—Carmustine—brain cancer	0.00012	0.000923	CcSEcCtD
Hydromorphone—Dermatitis—Carmustine—brain cancer	0.00012	0.000922	CcSEcCtD
Hydromorphone—Headache—Carmustine—brain cancer	0.000119	0.000917	CcSEcCtD
Hydromorphone—Vomiting—Temozolomide—brain cancer	0.000117	0.000899	CcSEcCtD
Hydromorphone—Urticaria—Etoposide—brain cancer	0.000117	0.000899	CcSEcCtD
Hydromorphone—Abdominal pain—Etoposide—brain cancer	0.000117	0.000895	CcSEcCtD
Hydromorphone—Body temperature increased—Etoposide—brain cancer	0.000117	0.000895	CcSEcCtD
Hydromorphone—Rash—Temozolomide—brain cancer	0.000116	0.000892	CcSEcCtD
Hydromorphone—Dermatitis—Temozolomide—brain cancer	0.000116	0.000891	CcSEcCtD
Hydromorphone—Headache—Temozolomide—brain cancer	0.000115	0.000886	CcSEcCtD
Hydromorphone—Nausea—Carmustine—brain cancer	0.000113	0.000869	CcSEcCtD
Hydromorphone—Nausea—Temozolomide—brain cancer	0.000109	0.00084	CcSEcCtD
Hydromorphone—Hypersensitivity—Etoposide—brain cancer	0.000109	0.000834	CcSEcCtD
Hydromorphone—Asthenia—Etoposide—brain cancer	0.000106	0.000812	CcSEcCtD
Hydromorphone—Pruritus—Etoposide—brain cancer	0.000104	0.000801	CcSEcCtD
Hydromorphone—Diarrhoea—Etoposide—brain cancer	0.000101	0.000774	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—brain cancer	9.75e-05	0.000748	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—brain cancer	9.38e-05	0.000719	CcSEcCtD
Hydromorphone—Rash—Etoposide—brain cancer	9.3e-05	0.000713	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—brain cancer	9.29e-05	0.000713	CcSEcCtD
Hydromorphone—Headache—Etoposide—brain cancer	9.24e-05	0.000709	CcSEcCtD
Hydromorphone—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	9.04e-05	0.0493	CbGpPWpGaD
Hydromorphone—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	8.86e-05	0.0484	CbGpPWpGaD
Hydromorphone—Nausea—Etoposide—brain cancer	8.76e-05	0.000672	CcSEcCtD
Hydromorphone—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	8.73e-05	0.0476	CbGpPWpGaD
Hydromorphone—CYP2D6—Xenobiotics—CYP2C9—brain cancer	5.49e-05	0.03	CbGpPWpGaD
Hydromorphone—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	5.28e-05	0.0288	CbGpPWpGaD
Hydromorphone—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	4.98e-05	0.0272	CbGpPWpGaD
Hydromorphone—UGT1A9—Irinotecan Pathway—APC—brain cancer	4.48e-05	0.0245	CbGpPWpGaD
Hydromorphone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	3.59e-05	0.0196	CbGpPWpGaD
Hydromorphone—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.49e-05	0.019	CbGpPWpGaD
Hydromorphone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	3.45e-05	0.0188	CbGpPWpGaD
Hydromorphone—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	2.9e-05	0.0158	CbGpPWpGaD
Hydromorphone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	2.47e-05	0.0135	CbGpPWpGaD
Hydromorphone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	2.35e-05	0.0128	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	2.34e-05	0.0128	CbGpPWpGaD
Hydromorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	2.28e-05	0.0124	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—CYP2C9—brain cancer	2.27e-05	0.0124	CbGpPWpGaD
Hydromorphone—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	2.25e-05	0.0123	CbGpPWpGaD
Hydromorphone—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	2.24e-05	0.0122	CbGpPWpGaD
Hydromorphone—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	1.87e-05	0.0102	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—CYP2C9—brain cancer	1.85e-05	0.0101	CbGpPWpGaD
Hydromorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	1.85e-05	0.0101	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—PTCH2—brain cancer	1.59e-05	0.00866	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—VAV1—brain cancer	1.56e-05	0.0085	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—IRS2—brain cancer	1.51e-05	0.00823	CbGpPWpGaD
Hydromorphone—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	1.5e-05	0.0082	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	1.49e-05	0.00814	CbGpPWpGaD
Hydromorphone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	1.47e-05	0.00803	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—OR14C36—brain cancer	1.39e-05	0.00759	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—OR4C12—brain cancer	1.39e-05	0.00759	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—PTCH2—brain cancer	1.39e-05	0.00759	CbGpPWpGaD
Hydromorphone—CYP3A4—Irinotecan Pathway—APC—brain cancer	1.27e-05	0.00691	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—OR4C12—brain cancer	1.26e-05	0.0069	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—OR14C36—brain cancer	1.26e-05	0.0069	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—OR14C36—brain cancer	1.22e-05	0.00666	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—OR4C12—brain cancer	1.22e-05	0.00666	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	1.22e-05	0.00664	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	1.21e-05	0.0066	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—PTCH2—brain cancer	1.18e-05	0.00642	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	1.14e-05	0.00619	CbGpPWpGaD
Hydromorphone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	1.12e-05	0.00613	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—OR14C36—brain cancer	1.11e-05	0.00605	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—OR4C12—brain cancer	1.11e-05	0.00605	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—OR4C12—brain cancer	1.03e-05	0.00563	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—OR14C36—brain cancer	1.03e-05	0.00563	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.83e-06	0.00536	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.69e-06	0.00529	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—OR14C36—brain cancer	9.37e-06	0.00511	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—OR4C12—brain cancer	9.37e-06	0.00511	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	9.32e-06	0.00508	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.73e-06	0.00476	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—SHH—brain cancer	8.18e-06	0.00446	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PTCH2—brain cancer	8.14e-06	0.00444	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—PTCH1—brain cancer	7.75e-06	0.00423	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—SMO—brain cancer	7.75e-06	0.00423	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—RELA—brain cancer	7.73e-06	0.00422	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—OR4C12—brain cancer	7.47e-06	0.00407	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—OR14C36—brain cancer	7.47e-06	0.00407	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—SHH—brain cancer	7.17e-06	0.00391	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PTCH2—brain cancer	7.14e-06	0.0039	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.11e-06	0.00388	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—ABR—brain cancer	7.04e-06	0.00384	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—SMO—brain cancer	6.8e-06	0.00371	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—PTCH1—brain cancer	6.8e-06	0.00371	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	6.56e-06	0.00358	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—OR14C36—brain cancer	6.55e-06	0.00357	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—OR4C12—brain cancer	6.55e-06	0.00357	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.42e-06	0.0035	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—ABR—brain cancer	6.39e-06	0.00349	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.38e-06	0.00348	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—DTX2—brain cancer	6.35e-06	0.00346	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.34e-06	0.00346	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—ABR—brain cancer	6.17e-06	0.00337	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—SHH—brain cancer	6.06e-06	0.00331	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PTCH2—brain cancer	6.04e-06	0.00329	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—PTCH1—brain cancer	5.74e-06	0.00313	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—SMO—brain cancer	5.74e-06	0.00313	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ABR—brain cancer	5.6e-06	0.00306	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—DTX2—brain cancer	5.57e-06	0.00304	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—OR14C36—brain cancer	5.53e-06	0.00302	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—OR4C12—brain cancer	5.53e-06	0.00302	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—ABR—brain cancer	5.22e-06	0.00285	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.2e-06	0.00284	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTCH2—brain cancer	4.81e-06	0.00262	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—ABR—brain cancer	4.74e-06	0.00258	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—DTX2—brain cancer	4.7e-06	0.00257	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HES5—brain cancer	4.66e-06	0.00254	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STRADA—brain cancer	4.52e-06	0.00247	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	4.46e-06	0.00243	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTCH2—brain cancer	4.22e-06	0.0023	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—SHH—brain cancer	4.2e-06	0.00229	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HES5—brain cancer	4.09e-06	0.00223	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—TRPC6—brain cancer	4.05e-06	0.00221	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—SMO—brain cancer	3.98e-06	0.00217	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PTCH1—brain cancer	3.98e-06	0.00217	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STRADA—brain cancer	3.97e-06	0.00216	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	3.91e-06	0.00213	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP2C9—brain cancer	3.89e-06	0.00212	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ABR—brain cancer	3.78e-06	0.00206	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—SHH—brain cancer	3.68e-06	0.00201	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GLI2—brain cancer	3.65e-06	0.00199	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTCH2—brain cancer	3.57e-06	0.00195	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—TRPC6—brain cancer	3.55e-06	0.00194	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PTCH1—brain cancer	3.49e-06	0.0019	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—SMO—brain cancer	3.49e-06	0.0019	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HES5—brain cancer	3.45e-06	0.00188	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GLI1—brain cancer	3.43e-06	0.00187	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STRADA—brain cancer	3.35e-06	0.00183	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—VAV1—brain cancer	3.34e-06	0.00182	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ABR—brain cancer	3.31e-06	0.00181	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—BSG—brain cancer	3.3e-06	0.0018	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	3.3e-06	0.0018	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SUFU—brain cancer	3.25e-06	0.00177	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GLI2—brain cancer	3.2e-06	0.00174	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP2C9—brain cancer	3.17e-06	0.00173	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GFAP—brain cancer	3.14e-06	0.00171	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—SHH—brain cancer	3.11e-06	0.0017	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—VAV1—brain cancer	3.03e-06	0.00165	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GLI1—brain cancer	3.01e-06	0.00164	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—TRPC6—brain cancer	3e-06	0.00164	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HEY1—brain cancer	2.97e-06	0.00162	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PTCH1—brain cancer	2.95e-06	0.00161	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—SMO—brain cancer	2.95e-06	0.00161	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	2.93e-06	0.0016	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—DLL1—brain cancer	2.92e-06	0.00159	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SUFU—brain cancer	2.85e-06	0.00155	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—IDH1—brain cancer	2.84e-06	0.00155	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ABR—brain cancer	2.8e-06	0.00153	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GFAP—brain cancer	2.75e-06	0.0015	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.73e-06	0.00149	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GLI2—brain cancer	2.7e-06	0.00147	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—BSG—brain cancer	2.69e-06	0.00147	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—VAV1—brain cancer	2.66e-06	0.00145	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HEY1—brain cancer	2.61e-06	0.00142	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—DLL1—brain cancer	2.56e-06	0.00139	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GLI1—brain cancer	2.54e-06	0.00139	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SHH—brain cancer	2.48e-06	0.00135	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—VAV1—brain cancer	2.47e-06	0.00135	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SUFU—brain cancer	2.41e-06	0.00131	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TRPC6—brain cancer	2.39e-06	0.0013	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SMO—brain cancer	2.35e-06	0.00128	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTCH1—brain cancer	2.35e-06	0.00128	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GFAP—brain cancer	2.32e-06	0.00127	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—IDH1—brain cancer	2.32e-06	0.00126	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.31e-06	0.00126	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—VAV1—brain cancer	2.25e-06	0.00123	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ENO2—brain cancer	2.25e-06	0.00123	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HEY1—brain cancer	2.2e-06	0.0012	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SHH—brain cancer	2.17e-06	0.00119	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—DLL1—brain cancer	2.16e-06	0.00118	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	2.12e-06	0.00116	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TRPC6—brain cancer	2.1e-06	0.00114	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTCH1—brain cancer	2.06e-06	0.00112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SMO—brain cancer	2.06e-06	0.00112	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	1.92e-06	0.00105	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.89e-06	0.00103	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOTCH2—brain cancer	1.88e-06	0.00102	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.86e-06	0.00101	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SHH—brain cancer	1.84e-06	0.001	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ENO2—brain cancer	1.83e-06	0.000999	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VAV1—brain cancer	1.79e-06	0.000977	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.77e-06	0.000966	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.74e-06	0.00095	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SMO—brain cancer	1.74e-06	0.00095	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	1.69e-06	0.000921	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.68e-06	0.000917	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	1.65e-06	0.000899	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.57e-06	0.000857	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VAV1—brain cancer	1.57e-06	0.000857	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HES1—brain cancer	1.54e-06	0.00084	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—brain cancer	1.49e-06	0.000814	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PDGFRA—brain cancer	1.47e-06	0.0008	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BSG—brain cancer	1.43e-06	0.000779	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	1.43e-06	0.000778	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SPP1—brain cancer	1.42e-06	0.000777	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BSG—brain cancer	1.42e-06	0.000773	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH2—brain cancer	1.39e-06	0.000759	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—brain cancer	1.35e-06	0.000739	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HES1—brain cancer	1.35e-06	0.000737	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VAV1—brain cancer	1.33e-06	0.000724	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—brain cancer	1.31e-06	0.000714	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IRS2—brain cancer	1.29e-06	0.000702	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	1.29e-06	0.000701	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SPP1—brain cancer	1.25e-06	0.000681	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—IDH1—brain cancer	1.23e-06	0.00067	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—IDH1—brain cancer	1.22e-06	0.000664	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—brain cancer	1.19e-06	0.000648	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HES1—brain cancer	1.14e-06	0.000623	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APC—brain cancer	1.14e-06	0.00062	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CG—brain cancer	1.14e-06	0.00062	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IRS2—brain cancer	1.13e-06	0.000616	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—brain cancer	1.11e-06	0.000603	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.1e-06	0.000599	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDGFRA—brain cancer	1.09e-06	0.000593	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SPP1—brain cancer	1.06e-06	0.000576	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—brain cancer	1.04e-06	0.000565	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CG—brain cancer	1.03e-06	0.000562	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—brain cancer	1e-06	0.000548	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APC—brain cancer	9.97e-07	0.000544	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	9.97e-07	0.000544	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.92e-07	0.000541	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ENO2—brain cancer	9.71e-07	0.00053	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ENO2—brain cancer	9.63e-07	0.000525	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IRS2—brain cancer	9.54e-07	0.00052	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BSG—brain cancer	9.34e-07	0.00051	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—brain cancer	9.08e-07	0.000496	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RELA—brain cancer	8.88e-07	0.000485	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB2—brain cancer	8.83e-07	0.000482	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APC—brain cancer	8.43e-07	0.00046	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CG—brain cancer	8.43e-07	0.00046	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CG—brain cancer	8.4e-07	0.000458	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—IDH1—brain cancer	8.03e-07	0.000438	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—brain cancer	8e-07	0.000437	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—brain cancer	7.8e-07	0.000426	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RELA—brain cancer	7.79e-07	0.000425	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—brain cancer	7.74e-07	0.000422	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—brain cancer	7.72e-07	0.000421	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—brain cancer	7.68e-07	0.000419	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—brain cancer	7.02e-07	0.000383	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—brain cancer	6.84e-07	0.000373	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—brain cancer	6.8e-07	0.000371	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	6.77e-07	0.00037	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—brain cancer	6.73e-07	0.000367	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RELA—brain cancer	6.58e-07	0.000359	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—brain cancer	6.54e-07	0.000357	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ENO2—brain cancer	6.35e-07	0.000346	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—brain cancer	6.26e-07	0.000341	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—brain cancer	6.12e-07	0.000334	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—brain cancer	5.96e-07	0.000325	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—brain cancer	5.93e-07	0.000323	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—brain cancer	5.9e-07	0.000322	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—brain cancer	5.78e-07	0.000315	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—brain cancer	5.72e-07	0.000312	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—brain cancer	5.49e-07	0.000299	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—brain cancer	5.37e-07	0.000293	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—brain cancer	5.14e-07	0.00028	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—brain cancer	5.04e-07	0.000275	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—brain cancer	4.99e-07	0.000272	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—brain cancer	4.64e-07	0.000253	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—brain cancer	4.54e-07	0.000247	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—brain cancer	4.51e-07	0.000246	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—brain cancer	4.45e-07	0.000243	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—brain cancer	4.42e-07	0.000241	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—brain cancer	3.81e-07	0.000208	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.91e-07	0.000159	CbGpPWpGaD
